CDMO Company's Shares Surge Over 12 Per Cent in Two Trading Sessions; Here’s Why
CDMO Company's Shares Surge Over 12 Per Cent in Two Trading Sessions; Here’s Why
The company's shares surged 10 per cent to hit the upper circuit at Rs 668.10 on the BSE. This marked the second consecutive session of gains for the stock
Under the agreement, Akums will receive an upfront payment of EUR 100 million (Rs 880 crore) to fund product development and secure European regulatory approvals for its oral liquid manufacturing facility.
Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC
The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share.
The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.
Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility
The inspection, conducted between December 9 and December 17, 2024, resulted in two procedural observations from the US FDA.
The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site operated by Apitoria Pharma Private Ltd, a wholly owned subsidiary of Aurobindo Pharma, located in Pashamylaram Village, Telangana.
Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl
From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
FIIs and DIIs Increase Stake: Small-cap Pharma Company Reports Over 11 Times Jump in Net Profit
The company reported an impressive over 11 times growth in net profit for the second quarter of FY25, with Profit After Tax (PAT) reaching Rs 17.94 crore compared to Rs 1.61 crore in the same period last year.
Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) significantly increased their holdings in Shilpa Medicare during Q2 of FY25.
Mukul Agrawal gains Rs 1,10,29,80,000 & Vijay Kedia gains 35,84,68,500 from this multibagger pharma stock; Scrip hit 20 per cent upper circuit & 52-week high
The shares of the company saw a spurt in volume by more than 2 times.
The stock gave multibagger returns of 200 per cent in 1 year, 850 per cent in 3 years and a whopping 3,000 per cent in 5 years.
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches!
With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence
With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence
This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth?
Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Vijay Kedia & Mukul Agrawal’s Portfolio Multibagger Pharma Stock Falls Over 14 Per Cent In Past 1 Hour; Here’s Why
The company has a market cap of over Rs 17,000 crore with a PE of 55x, an ROE of 27 per cent and an ROCE of 33 per cent.
The stock gave multibagger returns of 250 per cent in 1 year, 720 per cent in 3 years and a whopping 2,700 per cent in 5 years.
Multibagger Pharma Stock Hit 52-Week High As Board Announces Stock Split From Rs 5 to Rs 2 and Stellar Quarterly Results (Q2FY25) and Half-Yearly Results (H1FY25)
The stock is up by 85 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of 1,895 per cent in 5 years.
The stock is up by 85 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of 1,895 per cent in 5 years.
Multibagger Pharma Stock To Keep Under Radar As Board Likely To Announce Stock Split
The stock is up by 75 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of over 1,800 per cent in 5 years.
The stock is up by 75 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of over 1,800 per cent in 5 years.
Pharma Penny Stock At Rs 65 Enters Into An Mou With Vaibhav Kashinath Chaudhari & Mistycube Analytics To Enter French West African Market
The company has a market cap of Rs 76 crore and as of September 27, 2024, the stock is trading at Rs 65 per share on NSE.
The company has a market cap of Rs 76 crore and as of September 27, 2024, the stock is trading at Rs 65 per share on NSE.